HIMS 8-K: Smart Summary

On July 1, 2026, subsidiaries of Hims & Hers Health, Inc. entered into a $400,000,000 Master Receivables Purchase Agreement with JPMorgan Chase Bank, N.A., and the Company separately amended its existing Revolving Credit and Guaranty Agreement to permit and accommodate the new receivables facility.

• Master Receivables Purchase Agreement (RPA) — XeCare LLC and Apostrophe Pharmacy LLC (collectively, 'Sellers'), subsidiaries of Hims & Hers Health, Inc., as sellers; JPMorgan Chase Bank, N.A., as purchaser; effective July 1, 2026; Sellers may offer to sell eligible receivables for cash equal to the receivable balance minus an applicable Purchase Discount; Purchaser may decline to purchase in its sole discretion; initial term of 364 days, extendable an indefinite number of times by written agreement for periods of up to one year each
• Performance Undertaking — Hims & Hers Health, Inc., as guarantor, in favor of JPMorgan Chase Bank, N.A.; effective July 1, 2026; Company guarantees the Sellers' performance of their obligations under the RPA; does not guarantee collectability of receivables or creditworthiness of the Sellers
• Amendment No. 4 to Revolving Credit and Guaranty Agreement — Hims & Hers Health, Inc. as borrower, subsidiary borrowers and guarantors party thereto, lenders and issuing banks party thereto, and JPMorgan Chase Bank, N.A. as administrative agent and collateral agent; effective June 26, 2026; amends the Credit Agreement originally dated February 18, 2025 to permit entry into the RPA and Performance Undertaking, adds a new permitted indebtedness basket for RPA-related indebtedness, and makes related updates to permitted lien and collateral provisions; no material changes to interest provisions, fees, covenants, or events of default

• Purchaser Discretion — JPMorgan Chase Bank, N.A. may, in its sole discretion, decline to purchase any offered receivables from the Sellers
• Eligible Receivables — Only receivables meeting the eligibility criteria defined in the RPA may be offered for sale
• Customary Covenants and Representations — RPA is subject to customary covenants, representations and warranties, events of default, and termination provisions for facilities of this type
• Extension Requirement — Any extension of the 364-day initial term requires written agreement of the parties, with each extension for a period of up to one year

• Facility Limit — $400,000,000 maximum for eligible receivables under the RPA
• New Permitted Indebtedness Basket — Amendment adds a basket allowing indebtedness incurred in connection with the RPA in an aggregate outstanding principal amount not to exceed $400,000,000
• Purchase Price — Eligible receivables sold for cash equal to the receivable balance minus the applicable Purchase Discount as defined in the RPA